HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of Hypothyroid Graves' disease with extremely high titers of TSAb].

Abstract
Graves' ophthalmopathy in hypothyroid state is called Hypothyroid Graves' Disease, which is a comparatively rare disease. We experienced a case of a 57 year old man with severe exophthalmos and diplopia, which are typical symptoms of Graves' opthalmopathy, and with an extremely high thyroid-stimulating antibody(TSAb) level. He also had a firm diffuse goiter and hypothyroidism with positive anti-thyroglobulin and anti-thyroid microsomal antigen. These findings suggested Hashimoto's thyroiditis. Severity of ophthalmopathy and TSAb level were improved during replacement therapy with T4. Although a thyroid stimulation-blocking antibody was also detected in this patient, we thought that hypothyroidism in this case was based on destructive change in the thyroid with Hashimoto's thyroiditis. Therefore, we should be aware of the fact that there are cases of hypothyroidism with Graves' ophthalmopathy and a high level of TSAb.
AuthorsMiho Nakai, Yosuke Okada, Takahisa Tanikawa, Kazuko Kanda, Emiko Morita, Yoshiya Tanaka
JournalJournal of UOEH (J UOEH) Vol. 25 Issue 3 Pg. 333-9 (Sep 01 2003) ISSN: 0387-821X [Print] Japan
PMID14503045 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Immunoglobulins, Thyroid-Stimulating
  • Thyroxine
Topics
  • Graves Disease (drug therapy, etiology)
  • Hormone Replacement Therapy
  • Humans
  • Hypothyroidism (drug therapy, etiology)
  • Immunoglobulins, Thyroid-Stimulating (blood)
  • Male
  • Middle Aged
  • Thyroiditis, Autoimmune (complications, drug therapy)
  • Thyroxine (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: